Ignite Creation Date:
2024-05-06 @ 3:15 AM
Last Modification Date:
2024-10-26 @ 11:30 AM
Study NCT ID:
NCT02244710
Status:
COMPLETED
Last Update Posted:
2016-11-23
First Post:
2014-09-11
Brief Title:
EndoTic - Endothelium and Ticagrelor
Sponsor:
Fundación Investigación Sanitaria en León
Organization:
Fundación Investigación Sanitaria en León
Study Overview
Official Title:
EndoTic - Endothelium and Ticagrelor Pharmacological Effects Beyond Antiplatelet Therapy
Status:
COMPLETED
Status Verified Date:
2016-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Randomized clinical trial to assess the influence of treatment with ticagrelor or clopidogrel in the number of CECs Circulating Endothelial Cells and EPCs Endothelial Progenitor Cells in patients with ACS Acute Coronary Syndrome from baseline levels to chronic levels 1 month
Detailed Description:
ACS Patients in both treatment groups will be assessed
Baseline 48h and 1 month cell counts will be done for CECs and EPCs Platelet Function at 48h and 1month Adverse Events ECG and blood testing result will be also collected
Baseline 48h and 1 month cell counts will be done for CECs and EPCs Platelet Function at 48h and 1month Adverse Events ECG and blood testing result will be also collected
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2013-005042-11 | EUDRACT_NUMBER | None | None |